Get Social With Us

Biomanufacturing Capacity: The Bottleneck Moves Downstream

Presented at: ISPE Annual Meeting Orlando, FL, Nov 7-10, 2010

The industry is struggling to rebalance upstream and downstream processing. Why and how? Implications on world capacity? Topics covered include:

  • What is the status of capacity distribution and utilization within the biopharmaceutical industry?
  • The industry is struggling to rebalance upstream and downstream processing. Why and how? Implication on world capacity?
  • Advances in single-use processing steps are shifting the way that the industry thinks about capital investment in manufacturing facilities. Is this the technology of the future? What are the issues?